Arch Dis Child. Published Online First: 19 February 2008. doi:10.1136/adc.2008.138982
Archimedes |
Should Angiotensin converting enzyme inhibitors be used in children with Type 1 diabetes and Microalbuminuria?
1 University of Cambridge, United Kingdom
* To whom correspondence should be addressed. E-mail: rmw33{at}cam.ac.uk.
Accepted 7 February 2008
Abstract
A 14 yr-old girl with type-1 diabetes (T1D) attends clinic for her annual review appointment. An albumin creatinine ratio (ACR) on spot urine is 7.3mg/mmol. Her blood pressure is 125/67 and HbA1c 9.2%. Subsequently, three consecutive early morning urine samples have ACR of 6.8, 5.7 and 7.3 mg/mmol, respectively and when repeated a further 3 and 6 months later, they remain elevated. You are aware that in adult women with diabetes persistent microalbuminuria (MA) is defined as an ACR greater than 3.5 mg/mmol on 2 out of 3 successive occasions, and that in such adults, treatment with angiotensin converting enzyme inhibitors (ACEi) confers renoprotection. You wonder whether your patient should be treated.
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



